Literatur
-
1
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S.
Cardiomyocytes can be generated from marrow stromal cells in vitro.
J Clin Invest.
1999;
103
697-705
-
2
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S M, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine D M, Leri A, Anversa P.
Bone marrow cells regenerate infarcted myocardium.
Nature.
2001;
410
701-705
-
3
Pasumarthi K B, Field L J.
Cardiomyocyte cell cycle regulation.
Circ Res.
2002;
90
1044-1054
-
4
Strauer B E, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg R V, Kogler G, Wernet P.
Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction.
Dtsch Med Wochenschr.
2001;
126
932-938
-
5
Strauer B E, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg R V, Kogler G, Wernet P.
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
Circulation.
2002;
106
1913-1918
-
6
Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher A M.
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Circulation.
2002;
106
3009-3017
-
7
Stamm C, Westphal B, Kleine H D, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber C A, Freund M, Steinhoff G.
Autologous bone-marrow stem-cell transplantation for myocardial regeneration.
Lancet.
2003;
361
45-46
-
8
Wollert K C, Meyer G P, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H.
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Lancet.
2004;
364
141-148
-
9
Menasche P, Hagege A A, Vilquin J T, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau J P, Duboc D.
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
J Am Coll Cardiol.
2003;
41
1078-1083
-
10
Blau H M, Brazelton T R, Weimann J M.
The evolving concept of a stem cell: entity or function?.
Cell.
2001;
105
829-841
-
11
Balsam L B, Wagers A J, Christensen J L, Kofidis T, Weissman I L, Robbins R C.
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.
Nature.
2004;
428
668-673
-
12
Murry C E, Soonpaa M H, Reinecke H, Nakajima H, Nakajima H O, Rubart M, Pasumarthi K B, Virag J I, Bartelmez S H, Poppa V, Bradford G, Dowell J D, Williams D A, Field L J.
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.
Nature.
2004;
428
664-668
-
13
Cleland J G, Cohen-Solal A, Aguilar J C, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst W H, Hobbs F D, Korewicki J, Madeira H C, Preda I, Swedberg K, Widimsky J.
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Lancet.
2002;
360
1631-1639
Prof. Dr. med. Rüdiger von Harsdorf
Medizinische Klinik mit Schwerpunkt Kardiologie, Universitätsklinikum Charité
Augustenburger Platz 1 · 13353 Berlin
eMail: ruediger.harsdorf@charite.de
